Skip to main content
. 2018 Feb 28;9(21):15732–15739. doi: 10.18632/oncotarget.24596

Table 3. Survival data.

Patient’s details Alive at Recurrence
1. 65 yrs., F; R1 - T3N0 22 months No
2. 74 yrs., M; R2 - T4N1 16 months Liver metastases
3. 79 yrs., M; R2 - T4N1 10 months No
4. 76 yrs., F; R1 - T3N1 10 months No
5. 71 yrs., F; R1 - T3N1 5 months No
6. 74 yrs., M; R1 - T3N1 4 months No

Abbreviations: F: female, M: male.